Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
27.26
+0.47 (+1.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
Next >
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 08, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...
Via
Benzinga
Arcturus Therapeutics: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Why Arcturus Therapeutics Stock Is Soaring Today
March 29, 2023
Investors liked what they heard in its Q4 update.
Via
The Motley Fool
Arcturus Therapeutics's Return On Capital Employed Insights
March 29, 2023
Via
Benzinga
Dynavax Technologies Stock Sees Renewed Technical Strength
August 07, 2023
Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.
Via
Investor's Business Daily
3 Biotech Stocks to Buy Before the Breakout
July 28, 2023
Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch.
Via
InvestorPlace
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
July 24, 2023
William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair
Via
Benzinga
Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade
July 20, 2023
On Thursday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, from 78 to 81.
Via
Investor's Business Daily
3 Biotech Stocks for Getting Rich in 2023
July 18, 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
July 24, 2023
Via
Benzinga
Amicus Therapeutics Stock Sees Improving Market Leadership; Earns 81 RS Rating
July 17, 2023
On Monday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, to 81, up from 74 a day earlier.
Via
Investor's Business Daily
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
July 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 14, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
Via
Benzinga
Abcam Stock Earns Relative Strength Rating Upgrade
June 20, 2023
A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance.
Via
Investor's Business Daily
FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90
June 06, 2023
On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier.
Via
Investor's Business Daily
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
May 25, 2023
On Thursday, Gilead Sciences stock had its Relative Strength (RS) Rating upgraded to 81, up from 78 a day earlier.
Via
Investor's Business Daily
Ionis Pharmaceuticals Stock Sees IBD RS Rating Climb To 79
May 24, 2023
The Relative Strength Rating for Ionis Pharmaceuticals stock moved into a new percentile Wednesday, as it got a lift from 65 to 79.
Via
Investor's Business Daily
Amicus Therapeutics Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark
May 19, 2023
One key metric to look for in a stock is an 80-plus RS Rating. Amicus Therapeutics stock hit that mark, with a jump from 74 to 82 Friday.
Via
Investor's Business Daily
Ultragenyx Pharm Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
May 15, 2023
Ultragenyx Pharm shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.
Via
Investor's Business Daily
Analyst's Vote of Confidence: Arcturus' COVID-19 Vaccine Efforts Set to Pay Off in Japan and Beyond
May 11, 2023
HC Wainwright has upgraded Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) from Neutral to Buy with
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
May 11, 2023
Via
Benzinga
Unity Software, Tapestry, CIRCOR International And Other Big Stocks Moving Higher On Thursday
May 11, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday
March 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
March 30, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Semtech Corporation (NASDAQ: SMTC) shares dipped 12.7% to $28.00 in...
Via
Benzinga
S&P 500 Up 1%; Bluebird Bio Shares Plummet
March 29, 2023
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also...
Via
Benzinga
Stocks Rise As Investors Bet On Bank Recovery
March 29, 2023
Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 29, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
Nasdaq Rises 1%; US Pending Home Sales Increase In February
March 29, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.